Enterprise Financial Services Corp Edwards Lifesciences Corp Transaction History

Enterprise Financial Services Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $27,476 - $32,774	-267 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $251 - $314	3 Added 1.14%	267 $28,000
Q1 2021 May 13, 2021	BUY	$78.68 - $90.67 $2,675 - $3,082	34 Added 14.78%	264 $22,000
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $1,003 - $1,277	14 Added 6.48%	230 $21,000
Q2 2020 Aug 04, 2020	BUY	$57.54 - $76.95 $8,631 - $11,542	150 Added 227.27%	216 $15,000
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $52 - $81	1 Added 1.54%	66 $12,000
Q4 2019 Jan 28, 2020	BUY	$71.7 - $82.09 $573 - $656	8 Added 14.04%	65 $15,000
Q1 2019 Apr 26, 2019	BUY	$47.89 - $64.05 $1,867 - $2,497	39 Added 216.67%	57 $11,000
Q4 2018 Jan 25, 2019	BUY	$46.41 - $56.94 $324 - $398	7 Added 63.64%	18 $3,000
Q3 2017 Oct 27, 2017	BUY	$36.29 - $38.83 $399 - $427	11	11 $1,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.